AnaptysBio News - ANAB

Company Name	Stock Ticker Symbol	Market	Type
AnaptysBio Inc	ANAB	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.00	0.00%	18.87	04:09:46

Open Price	Low Price	High Price	Close Price	Prev Close
				18.87

more quote information »

Recent News

Date	Time	Source	Heading
4/25/2024	8:52	IHNW	FeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
4/24/2024	09:00	PRNUS	Actym Therapeutics Appoints Thomas Smart as CEO
3/11/2024	16:41	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
3/11/2024	16:36	EDGAR2	Form 10-K - Annual report [Section 13 and 15(d), not S-K..
3/11/2024	16:19	EDGAR2	Form 8-K - Current report
2/29/2024	09:15	GLOBE	Anaptys to Present at TD Cowen’s 44th Annual Health Care..
2/14/2024	10:01	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/14/2024	08:35	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
1/31/2024	09:15	GLOBE	Anaptys to Present at Guggenheim’s 6th Annual Biotechnology..
1/09/2024	19:08	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/09/2024	19:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/05/2024	17:01	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/05/2024	17:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/05/2024	16:59	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/05/2024	16:58	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/05/2024	16:57	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/05/2024	16:52	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/05/2024	16:51	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/05/2024	16:09	EDGAR2	Form 8-K - Current report
11/27/2023	16:17	EDGAR2	Form 8-K - Current report
11/27/2023	16:15	GLOBE	Anaptys Expands Immune Cell Modulator Pipeline with..
11/07/2023	16:15	GLOBE	Anaptys Named a BioSpace 2024 Best Places to Work Winner
11/02/2023	16:21	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/02/2023	16:18	EDGAR2	Form 8-K - Current report
11/02/2023	16:15	GLOBE	Anaptys Announces Third Quarter 2023 Financial Results and..
11/01/2023	09:15	GLOBE	Anaptys Announces Participation in November Investor..
10/25/2023	16:43	EDGAR2	Form 8-K - Current report
10/11/2023	09:15	GLOBE	Anaptys to Present Phase 1 Data on ANB032, its BTLA Agonist..
10/10/2023	09:01	EDGAR2	Form 8-K - Current report
10/09/2023	08:43	DJN	Anaptys Sees Positive Trial Results for Imsidolimad..
10/09/2023	08:15	GLOBE	Anaptys to Provide Overview of Rosnilimab, a PD-1 Agonist,..
10/09/2023	08:00	GLOBE	Anaptys Announces Positive Top-Line Phase 3 Clinical Trial..
9/18/2023	18:14	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/18/2023	18:11	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/18/2023	18:09	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
9/18/2023	16:18	EDGAR2	Form 8-K - Current report
9/18/2023	16:15	GLOBE	AnaptysBio Announces Appointment of John Orwin as Chairman..
9/12/2023	09:15	GLOBE	AnaptysBio to Present at the Stifel 2023 Immunology and..
8/07/2023	16:21	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/07/2023	16:18	EDGAR2	Form 8-K - Current report
8/07/2023	16:15	GLOBE	AnaptysBio Announces Second Quarter 2023 Financial..
7/31/2023	14:27	DJN	AnaptysBio Shares Rise 11% After Jemperli Plus Chemotherapy..
7/31/2023	13:34	GLOBE	AnaptysBio- and GSK-Partnered Immuno-Oncology Agent JEMPERLI..
5/30/2023	16:15	GLOBE	AnaptysBio Announces Participation in Upcoming Investor..
5/11/2023	16:15	GLOBE	AnaptysBio Announces First Quarter 2023 Financial Results..
5/02/2023	09:15	GLOBE	AnaptysBio Announces British Journal of Dermatology..